» Articles » PMID: 38414464

Cystatins: Unravelling the Biological Implications for Neuroprotection

Overview
Journal Arch Med Sci
Specialty General Medicine
Date 2024 Feb 28
PMID 38414464
Authors
Affiliations
Soon will be listed here.
Abstract

Cystatins, a family of proteins known for their inhibitory role against cysteine proteases, have garnered significant attention in the field of neurodegeneration. Numerous genetic, experimental, and clinical studies concerning cystatin C suggest it plays an important role in the course of neurodegenerative diseases. Its beneficial effects are associated with cysteine protease inhibition, impact on β-amyloid aggregation, as well as regulation of cell proliferation, autophagy, and apoptosis. Cystatin isolated from chicken egg white, called ovocystatin, has been widely used in medical and pharmaceutical research due to its structural and biological similarities to human cystatin C. This article focuses on the potential use of cystatins, with special emphasis on easily obtained ovocystatin, in the treatment of neurodegenerative diseases, such as dementia. The current evidence on cystatin use has shed light on its mechanisms of action and therapeutic implications for neuroprotection and maintenance of cognitive functions.

Citing Articles

Distinct Urinary Proteome Changes Across Estimated Glomerular Filtration Rate Stages in a Cohort of Black South Africans.

Khoza S, George J, Naicker P, Stoychev S, Mokoena R, Govender I Int J Mol Sci. 2025; 26(4).

PMID: 40004202 PMC: 11855517. DOI: 10.3390/ijms26041740.

References
1.
Tiwari S, Atluri V, Kaushik A, Yndart A, Nair M . Alzheimer's disease: pathogenesis, diagnostics, and therapeutics. Int J Nanomedicine. 2019; 14:5541-5554. PMC: 6650620. DOI: 10.2147/IJN.S200490. View

2.
Hook V, Kindy M, Hook G . Inhibitors of cathepsin B improve memory and reduce beta-amyloid in transgenic Alzheimer disease mice expressing the wild-type, but not the Swedish mutant, beta-secretase site of the amyloid precursor protein. J Biol Chem. 2008; 283(12):7745-53. DOI: 10.1074/jbc.M708362200. View

3.
Taupin P, Ray J, Fischer W, Suhr S, Hakansson K, Grubb A . FGF-2-responsive neural stem cell proliferation requires CCg, a novel autocrine/paracrine cofactor. Neuron. 2001; 28(2):385-97. DOI: 10.1016/s0896-6273(00)00119-7. View

4.
Pirttila T, Lukasiuk K, Hakansson K, Grubb A, Abrahamson M, Pitkanen A . Cystatin C modulates neurodegeneration and neurogenesis following status epilepticus in mouse. Neurobiol Dis. 2005; 20(2):241-53. DOI: 10.1016/j.nbd.2005.03.006. View

5.
Hansson S, Andreasson U, Wall M, Skoog I, Andreasen N, Wallin A . Reduced levels of amyloid-beta-binding proteins in cerebrospinal fluid from Alzheimer's disease patients. J Alzheimers Dis. 2009; 16(2):389-97. DOI: 10.3233/JAD-2009-0966. View